Agfa names new Impax sales team
Agfa names new Impax sales teamAgfa continues to solidify the integration of Sterling Diagnostic Imaging assets into its PACS and conventional imaging businesses (PNN 8/99). Most recently, the PACS and film giant revamped its sales
Agfa names new Impax sales team
Agfa continues to solidify the integration of Sterling Diagnostic Imaging assets into its PACS and conventional imaging businesses (
PNN
8/99). Most recently, the PACS and film giant revamped its sales organization, separating the Impax digital image management and computed radiography business functions from its conventional imaging and hard-copy systems sales. Agfa also announced several key appointments to its sales teams.
John Scarano will now head up the Impax North American sales force. Those reporting to Scarano include John DeSantis, who previously directed Agfas military radiology sales and will now be responsible for Impax sales to the government; Andrea Harding, who had been responsible for western region PACS sales at Sterling and will now manage commercial Impax sales in the central and western regions; and Anthony Passarello, who was Agfas director of southeastern regional sales and will now lead Impax sales for the commercial market in the northeast and southern regions.
In the new Imaging Systems group, Bruce Gower will handle sales in the corporate healthcare sector. He was previously with Sterling as zone general manager.
- Search again
- Homepage
ASCO: Study Reveals Significant Racial/Ethnic Disparities with PSMA PET Use for Patients with mPCa
May 30th 2025Latinx patients with metastatic prostate cancer were 63 percent less likely than non-Hispanic White patients to have PSMA PET scans, according to a study of 550 patients presented at the American Society of Clinical Oncology (ASCO) conference.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.
New MRI Study Questions Use of Corticosteroid Injections for Knee OA
May 27th 2025Two years after intraarticular knee injections for knee osteoarthritis (OA), study participants who had corticosteroid knee injections had greater OA progression than control patients while the use of hyaluronic acid injections was associated with less OA progression.
